NDC 46014-0602 – Selexipag
Selexipag .2 mg/1 · Capsule
Product NDC46014-0602
Product details
- Brand name
- Selexipag
- Generic name
- Selexipag
- Labeler
- Excella GmbH & Co. KG
- Dosage form
- Capsule
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketed since
- December 22, 2015
- Listing expires
- December 31, 2026
Active ingredients
- Selexipag .2 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 46014-0602-6 | 60 CAPSULE in 1 BOTTLE (46014-0602-6) |
Other Selexipag products
- 46014-0621 Selexipag .2 mg/1 · Capsule · Excella GmbH & Co. KG
- 46014-0608 Selexipag .8 mg/1 · Capsule · Excella GmbH & Co. KG
- 46014-6280 · Kit · Excella GmbH & Co. KG
- 70771-1800 Selexipag 1600 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1799 Selexipag 1400 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1798 Selexipag 1200 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1797 Selexipag 1000 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1796 Selexipag 800 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1795 Selexipag 600 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1794 Selexipag 400 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1793 Selexipag 200 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70710-1558 Selexipag 1600 ug/1 · Tablet, Film Coated · Zydus Pharmaceuticals (USA) Inc.